PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
-1.64%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$13.5B
AUM Growth
-$1.11B
(-7.6%)
Cap. Flow
-$762M
Cap. Flow
% of AUM
-5.65%
Top 10 Holdings %
Top 10 Hldgs %
31.48%
Holding
316
New
26
Increased
60
Reduced
135
Closed
54
Top Buys
| 1 |
Adobe
ADBE
|
$70.4M |
| 2 |
Zscaler
ZS
|
$61.7M |
| 3 |
Datadog
DDOG
|
$44.8M |
| 4 |
Pinduoduo
PDD
|
$44.4M |
| 5 |
Tesla
TSLA
|
$43M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$94.1M |
| 2 |
Apple
AAPL
|
$68.9M |
| 3 |
Mercado Libre
MELI
|
$68.1M |
| 4 |
Alibaba
BABA
|
$59.7M |
| 5 |
Sanofi
SNY
|
$53.9M |
Sector Composition
| 1 | Technology | 41.63% |
| 2 | Healthcare | 21.34% |
| 3 | Financials | 17.68% |
| 4 | Communication Services | 9.74% |
| 5 | Consumer Discretionary | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Golub Capital BDC
GBDC
$3.93B
| $3.08M | 0.02% |
209,880
-45,000
| -18% | -$660K |
|
227
Insulet
PODD
$24.5B
| $3.03M | 0.02% |
18,971
| – | – |
|
228
Zai Lab
ZLAB
$3.42B
| $2.78M | 0.02% |
114,536
-66,747
| -37% | -$1.62M |
|
229
Huazhu Hotels Group
HTHT
$11.5B
| $2.69M | 0.02% |
68,167
+7,501
| +12% | +$296K |
|
230
Bioceres Crop Solutions
BIOX
$163M
| $2.11M | 0.02% |
+187,032
| New | +$2.11M |
|
231
Shoals Technologies Group
SHLS
$1.2B
| $1.37M | 0.01% |
75,000
-409,000
| -85% | -$7.46M |
|
|
NARI
232
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $799K | 0.01% |
12,224
-3,386
| -22% | -$221K |
|
233
Evolent Health
EVH
$1.11B
| $651K | ﹤0.01% |
23,910
-22,763
| -49% | -$620K |
|
234
Lantheus
LNTH
$3.72B
| $648K | ﹤0.01% |
9,327
-3,013
| -24% | -$209K |
|
235
QuidelOrtho
QDEL
$1.95B
| $601K | ﹤0.01% |
8,234
-2,141
| -21% | -$156K |
|
236
Inspire Medical Systems
INSP
$2.56B
| $534K | ﹤0.01% |
2,690
-262,492
| -99% | -$52.1M |
|
237
Exact Sciences
EXAS
$10.2B
| $507K | ﹤0.01% |
7,432
-1,808
| -20% | -$123K |
|
238
iRhythm Technologies
IRTC
$5.82B
| $481K | ﹤0.01% |
5,107
-1,718
| -25% | -$162K |
|
239
Privia Health
PRVA
$2.86B
| $477K | ﹤0.01% |
20,742
-7,933
| -28% | -$182K |
|
240
Natera
NTRA
$23.1B
| $404K | ﹤0.01% |
9,126
-5,674
| -38% | -$251K |
|
241
Bruker
BRKR
$4.68B
| $329K | ﹤0.01% |
5,277
-698
| -12% | -$43.5K |
|
242
NXP Semiconductors
NXPI
$57.2B
| $300K | ﹤0.01% |
1,500
-1,100
| -42% | -$220K |
|
243
Standard BioTools
LAB
$497M
| $290K | ﹤0.01% |
100,000
| – | – |
|
244
Liberty Live Group Series C
LLYVK
$8.88B
| $275K | ﹤0.01% |
+8,580
| New | +$275K |
|
245
Pacira BioSciences
PCRX
$1.19B
| $267K | ﹤0.01% |
8,705
| – | – |
|
|
CERE
246
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $235K | ﹤0.01% |
10,762
-900,000
| -99% | -$19.6M |
|
247
Tandem Diabetes Care
TNDM
$850M
| $233K | ﹤0.01% |
11,210
| – | – |
|
248
AtriCure
ATRC
$1.76B
| $233K | ﹤0.01% |
5,314
-10,101
| -66% | -$442K |
|
249
Tactile Systems Technology
TCMD
$300M
| $182K | ﹤0.01% |
+12,981
| New | +$182K |
|
250
Stereotaxis
STXS
$264M
| $121K | ﹤0.01% |
76,687
| – | – |
|